Innate Pharma SA

IPHA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 163 employees
265
SEC Filings
$1.83
Close 2026-05-29
163
Employees

Latest Stock Quote

IPHA 2026-05-29 $1.83 O:$1.88 H:$1.92 L:$1.83 Vol:0.0M VWAP:$1.8681
origin leaf: 03093b40d00f3a566945ab46278ef8b1782f314b24901200c482895a7d15a90c

265 total filings indexed. 265 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001598599
TickerIPHA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedI0
Websitehttps://www.innate-pharma.com
Listed2015-09-09

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7f968dd5699087e50f1a2bf095e2ed48f4992df43653d3726749f579b5768874
parent: ca7c09b5c6e537f953b0140a00d81afe4922a338dd54605fac649a068a037bef
content hash: 6771304cced95f6e3451938ba47a39a4a4339ea716373c7ead288f9e9f5f1cb7
signed: 2026-06-02T19:01:32.874Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf